Recombinant COVID-19 Vaccine (Sf9 Cell)
WSKCT004
Unknown mab completed
Quick answer
Recombinant COVID-19 Vaccine (Sf9 Cell) for COVID-19 is a Unknown program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- COVID-19
- Phase
- Unknown
- Modality
- mab
- Status
- completed